Impact of NR3C1 rs41423247 (BclI) Polymorphism on Disease Severity in Alopecia Areata
Key facts
- Who runs it
- Benha University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 120 people enrolled
- Started
- 1 Nov 2023
- Ended
- 1 Dec 2024
- Type of study
- Observational, 2 groups
- Record updated
- 6 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Clinically diagnosed alopecia areata
- Age ≥ 18 years
- Both sexes
- Willingness to participate and provide informed consent
- Apparently healthy individuals
- No history of autoimmune disease
- Age- and sex-matched to cases
- Provided informed consent
Who cannot take part
- Current systemic immunosuppressive therapy
- Presence of other autoimmune or inflammatory diseases
- Pregnancy or lactation
- Refusal to participate
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Alopecia areata is an autoimmune, non-scarring hair loss disorder with multifactorial pathogenesis. The glucocorticoid receptor gene (NR3C1) plays an essential role in immune regulation and inflammatory response. The rs41423247 polymorphism (BclI) may influence glucocorticoid sensitivity and disease activity. This study aims to investigate the association between NR3C1 rs41423247 polymorphism and susceptibility to alopecia areata and to evaluate its correlation with disease severity using the Severity of Alopecia Tool (SALT) score.
The 2 groups in the trial
- Group 1: Alopecia Areata Patients
Participants diagnosed clinically with alopecia areata (n = 60). Peripheral blood samples will be collected for genetic analysis of NR3C1 rs41423247 polymorphism. Disease severity will be assessed using SALT score.
- Group 2: Healthy Controls
Age- and sex-matched healthy individuals without autoimmune disease (n = 60). Peripheral blood samples will be collected for genetic analysis of NR3C1 rs41423247 polymorphism.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of Glucocorticoid Receptor Gene Polymorphism in Alopecia Areata
- Record updated
- 6 March 2026